Mathematician, physicist and information scientist Prof. Fabian Theis has won the 2023 Gottfried Wilhelm Leibniz Prize.The award is considered the most prestigious research prize in Germany and is awarded by the German Research Foundation (DFG); it is endowed with 2.5 million...

Read more

With this funding, the EU supports scientists at an early stage of their career. Two of a total of 408 grants have been awarded to DZHK scientists this year: Dr Gabriele G. Schiattarella from the DZHK partner site in Berlin is investigating the molecular mechanisms of heart...

Read more

16 scientists of the German Centre for Cardiovascular Research (DZHK) are among the most cited researchers worldwide and thus among the most influential experts in their field of research. The list of "Highly Cited Researchers" is published every year by the analysis company...

Read more

Research group led by Heidelberg University Hospital identified enzyme that modifies motor proteins of heart muscle cells and thus influences their function / Results published in Nature Communications

Read more

An overactive enzyme that causes an inherited form of high blood pressure also appears to protect against hypertension-induced cardiac damage. A team of researchers from the Max Delbrück Center, ECRC, and DZHK led by Enno Klußmann explains in the journal Circulation how this...

Read more

The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of oral anticoagulation in patients with atrial high rate episodes (AHRE) is going to be terminated prematurely. The reason for early termination is an observed trend towards futility for efficacy...

Read more

Almost a year after a SARS-CoV-2 infection, more than half of the participants in a Frankfurt study reported heart problems, such as tachycardia, chest pain and exercise intolerance: that is, symptoms worsening after even minor exertion. A team led by Dr Valentina Puntmann and...

Read more

A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents further adverse cardiovascular events after a heart attack compared with taking the drugs separately. That's the finding of the Europe-wide SECURE study, which has now been...

Read more

Patients with heart failure frequently also suffer from atrial fibrillation. Their heart then beats irregularly and often too fast, further worsening the heart failure , which may lead to hospitalization. A study funded by the German Center for Cardiovascular Research (DZHK) is...

Read more

Patients with atrial fibrillation benefit from early rhythm-maintenance therapy. It prevents complications better than the usual treatment. This is the result of the EAST-AFNET 4 study conducted by the Atrial Fibrillation NETwork (AFNET). Analyses of various subgroups of the...

Read more